Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Stacie Jones and Robert Pesek.

 
Connection Strength
  
 
 
2.198
  
  1. Pesek RD, Rettiganti M, O'Brien E, Beckwith S, Daniel C, Luo C, Scurlock AM, Chandler P, Levy RA, Perry TT, Kennedy JL, Chervinskiy S, Vonlanthen M, Casteel H, Fiedorek SC, Gibbons T, Jones SM. Effects of allergen sensitization on response to therapy in children with eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2017 08; 119(2):177-183.
    View in: PubMed
    Score: 0.563
  2. Pesek RD, Jones SM. Current and Emerging Therapies for IgE-Mediated Food Allergy. Curr Allergy Asthma Rep. 2016 Apr; 16(4):28.
    View in: PubMed
    Score: 0.516
  3. Kohley A, Attwal S, Jones SM, Akmyradov C, Chandler P, Tootle C, Nawaz S, Ayers T, Kawatu D, Pesek RD. Impact of Atopic Status on Clinical Presentation and Treatment Response in Pediatric Patients With Eosinophilic Esophagitis. J Allergy Clin Immunol Pract. 2024 Dec; 12(12):3358-3362.
    View in: PubMed
    Score: 0.231
  4. Jones SM, Anvari S, Coleman A, Pesek RD, Kloepfer KM, Perry TT, Jefferson AA, Doan D, Andres A, Doderer M, Hilbun A, Solomon R, Scurlock AM. Food insecurity and allergic diseases: A?call to collective action. J Allergy Clin Immunol. 2024 02; 153(2):359-367.
    View in: PubMed
    Score: 0.218
  5. Jones SM, Kim EH, Nadeau KC, Nowak-Wegrzyn A, Wood RA, Sampson HA, Scurlock AM, Chinthrajah S, Wang J, Pesek RD, Sindher SB, Kulis M, Johnson J, Spain K, Babineau DC, Chin H, Laurienzo-Panza J, Yan R, Larson D, Qin T, Whitehouse D, Sever ML, Sanda S, Plaut M, Wheatley LM, Burks AW. Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Lancet. 2022 01 22; 399(10322):359-371.
    View in: PubMed
    Score: 0.193
  6. Carlisle A, Kennedy JL, Chervinskiy S, Jones SM, Pesek RD. Successful desensitization in a pediatric patient with acetazolamide allergy. Ann Allergy Asthma Immunol. 2018 10; 121(4):508-509.
    View in: PubMed
    Score: 0.151
  7. Jones SM, Agbotounou WK, Fleischer DM, Burks AW, Pesek RD, Harris MW, Martin L, Thebault C, Ruban C, Benhamou PH. Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch. J Allergy Clin Immunol. 2016 Apr; 137(4):1258-1261.e10.
    View in: PubMed
    Score: 0.128
  8. Petitto J, Chervinskiy SK, Scurlock AM, Perry TT, Jones SM, Pesek RD. Successful clarithromycin desensitization in a macrolide-sensitive pediatric patient. J Allergy Clin Immunol Pract. 2013 May-Jun; 1(3):307-8.
    View in: PubMed
    Score: 0.105
  9. Price AS, Jefferson-Shah AA, Pesek RD, Ararat E, Nawaz SF, Pertzborn M, Cobb K, Long H, Miller MY, Whitaker BN, Jones SM, Stewart S, Liu D, Perry TT. Multidisciplinary care in pediatric severe asthma: A?comparative outcomes analysis. J Allergy Clin Immunol Glob. 2025 May; 4(2):100417.
    View in: PubMed
    Score: 0.059
  10. Virkud YV, Burks AW, Steele PH, Edwards LJ, Berglund JP, Jones SM, Scurlock AM, Perry TT, Pesek RD, Vickery BP. Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy. J Allergy Clin Immunol. 2017 Mar; 139(3):882-888.e5.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.